67Cu-based AlphaFlare therapeutic (NUCLIDIUM)

N/A

Report date: 2025/11/14 17:20:08
NME

Base Information

Drug Name67Cu-based AlphaFlare therapeutic (NUCLIDIUM)
Drug Alias Name67Cu-based AlphaFlare™ therapeutic (NUCLIDIUM)67Cu-AlphaFlare
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Copper > 67CuRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionIonising radiation emitters
TargetsUpdating
Therapy Area/IndicationsHead and Neck NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNuclidium AG
China Registration ClassN/A

Develop Information

Active CompaniesNuclidium AG
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A